1. Home
  2. PLAB vs ADPT Comparison

PLAB vs ADPT Comparison

Compare PLAB & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • ADPT
  • Stock Information
  • Founded
  • PLAB 1969
  • ADPT 2009
  • Country
  • PLAB United States
  • ADPT United States
  • Employees
  • PLAB N/A
  • ADPT N/A
  • Industry
  • PLAB Semiconductors
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLAB Technology
  • ADPT Health Care
  • Exchange
  • PLAB Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • PLAB 1.3B
  • ADPT 1.1B
  • IPO Year
  • PLAB 1987
  • ADPT 2019
  • Fundamental
  • Price
  • PLAB $19.45
  • ADPT $9.03
  • Analyst Decision
  • PLAB Strong Buy
  • ADPT Buy
  • Analyst Count
  • PLAB 1
  • ADPT 6
  • Target Price
  • PLAB $35.00
  • ADPT $9.83
  • AVG Volume (30 Days)
  • PLAB 608.6K
  • ADPT 3.0M
  • Earning Date
  • PLAB 05-21-2025
  • ADPT 05-01-2025
  • Dividend Yield
  • PLAB N/A
  • ADPT N/A
  • EPS Growth
  • PLAB 5.99
  • ADPT N/A
  • EPS
  • PLAB 2.35
  • ADPT N/A
  • Revenue
  • PLAB $862,750,000.00
  • ADPT $189,527,000.00
  • Revenue This Year
  • PLAB $2.60
  • ADPT $21.20
  • Revenue Next Year
  • PLAB $6.56
  • ADPT $21.99
  • P/E Ratio
  • PLAB $8.25
  • ADPT N/A
  • Revenue Growth
  • PLAB N/A
  • ADPT 8.61
  • 52 Week Low
  • PLAB $16.46
  • ADPT $2.99
  • 52 Week High
  • PLAB $31.60
  • ADPT $10.28
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 55.31
  • ADPT 57.82
  • Support Level
  • PLAB $18.59
  • ADPT $8.38
  • Resistance Level
  • PLAB $19.42
  • ADPT $9.51
  • Average True Range (ATR)
  • PLAB 0.47
  • ADPT 0.66
  • MACD
  • PLAB 0.24
  • ADPT 0.16
  • Stochastic Oscillator
  • PLAB 87.12
  • ADPT 63.02

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: